We invest in companies with two characteristics:

        1. Intense customer love, and

2. Explosive growth.

These include the next generation of leaders in across renewable energy, digital health, the life sciences, online retail, software, and entertainment.

Our framework (love and explosive growth) allows us to systematically identify these opportunities early


Latest Investor Letters and Articles

The Team

David Birkbeck

Advisor, Investment Committee


Director David Birkbeck is CFO of Tanarra Capital, a partner and investor in our fund. Tanarra Capital is a ~$1.7 billion institutional asset management firm, with investments across private equity, public markets, credit, and venture capital.


David has set up multiple financial institutions across a distinguished career in investment banking, private equity and funds management, and we are fortunate to have the benefit of his experience and expertise.

Anna Satouris

Client Relationship Manager


Anna oversees client relations for the fund.


Anna joined Frazis Capital Partners from Westpac, where she worked on a number of key programs, such as the Women In Leadership Initiative, and the Moon and Back Initiative, spearheading corporate agendas and targets such as equality in the workplace and improving employee engagement. Prior to Westpac she worked as an HR consultant for BT Financial Group.


Anna has a Bachelor of Commerce from Notre Dame.

Michael Frazis

Portfolio Manager, Managing Partner

Prior to founding the firm, Michael spent five years in private equity in London, after completing internships in Goldman Sachs Special Situations Group and the Boston Consulting Group. Michael read Chemistry at Oxford University, and has a Masters of Finance from the London School of Economics.


At Oxford, Michael’s research focused on the scale-up of enzyme-catalyzed fuel cells in the same laboratory that pioneered lithium batteries. Michael came first in Australia in the 2006 Chemistry Olympiad. 

Joel Tomaino

Senior Analyst


Prior to joining Frazis Capital Partners, Joel worked as an Investment Analyst at Alium Capital who run a global long/short equities fund and a cross-over fund with listed and private equity investments focusing on technology & innovation. Previous to this, Joel worked in the Corporate Advisory team at Evans and Partners on debt and equity transactions. Joel completed a Bachelor of Commerce from Monash University and has completed his Chartered Financial Analyst Level 1 accreditation.

Robert Stretch, MD

Advisor (Life Sciences)


Dr. Robert Stretch is a specialist in Pulmonary, Critical Care & Sleep Medicine, and advises the firm on matters relating to the life sciences. 

After graduating from Yale School of Medicine in 2014, Rob completed subspecialty training at BIDMC in Boston and UCLA Medical Center in Los Angeles.

Rob is board-certified by the American Board of Internal Medicine (ABIM). Through his firm AURUS Medical Group and in partnership with TeleICU service provider RemoteICU, Rob provides critical care support to U.S. hospitals from Sydney, Australia.




The information in this website has been prepared and issued by Frazis Capital Partners Pty Ltd ABN 16 625
521 986 as a corporate authorised representative (CAR No. 1263393) of Frazis Capital Management Pty Ltd
ABN 91 638 965 910 AFSL 521445 (Frazis Capital or we or us). The information contained in this website is
for general information only and is not intended to provide you with financial advice or take into account
your objectives, financial situation or needs. You should consider, with your professional adviser, whether
the information is suitable for your circumstances.

Please note past investment performance is not a reliable indicator of future investment performance and
no guarantee of performance, the return of capital or a particular rate of return is provided. Whilst we
believe the material in this website is correct, no warranty of accuracy, reliability or completeness is given,
except for liability under statute which can’t be excluded.